National Institutes of Health

Description

The Chronic Kidney Disease Biomarkers Consortium [CKD BioCon] was established in September 2009 as a result of RFA-DK-08-015 [Chronic Kidney Disease Biomarker Discovery and Validation Consortium (U01)] to develop, validate and qualify biomarkers based on existing biosamples from well-characterized CKD patients with longitudinal follow-up. The CKD BioCon consists of six Participating Centers (PCs) and is actively engaged in multiple research protocols. The initial Funding Opportunity Announcement to establish the Consortium did not provide for a Data Coordinating Center (DCC). Given the complexity of the work to be performed by the consortium, a study coordination group was established through a subcontract to one of the PCs to provide logistical support and coordination of consortial meetings. However, the expertise needed to coordinate multicenter studies and perform advanced statistical analyses is limited.

Who can apply

• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV